Collectively, these multi-tiered validation data robustly support the involvement of ASPHD2, GCH1, and GK in tuberculosis pathogenesis and immune activation, highlighting their potential as protein-level biomarkers for the assessment of treatment response. The gene discussed is GK; the disease is tuberculosis.